Status:
COMPLETED
Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population Part II
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborating Sponsors:
Eli Lilly and Company
St. Joseph's Health Care London
Conditions:
Diabetes Mellitus
Schizophrenia
Eligibility:
All Genders
18-75 years
Brief Summary
The purpose of this study is to learn more about the relationship between serious mental illness and the detection and management of diabetes and pre-diabetic conditions. Patients who have been diagno...
Detailed Description
Many studies suggest that the extensive psychiatric needs of some patients could take attention away from management of other health problems and from the usual health promotion services physicians pr...
Eligibility Criteria
Inclusion
- Patients active in current Regional Mental Health Care London, Specialized Adult London Ambulatory Care and Assertive Community Treatment programs with known diagnosis of a Psychotic Disorder and/or use of Novel Antipsychotics.
- Must have family physician contact and ability to consent to medical care.
Exclusion
- Any patient with declaration on file stating incapable of consenting to medical treatment.
Key Trial Info
Start Date :
May 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2007
Estimated Enrollment :
39 Patients enrolled
Trial Details
Trial ID
NCT00377117
Start Date
May 1 2006
End Date
July 1 2007
Last Update
November 6 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Regional Mental Health Care London
London, Ontario, Canada, N6A 4H1